Clinical Trials
2 trialsNCT06685796 2024-11-13
A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast Cancer
BeBetter Med Inc
Phase 2 Recruiting
NCT03254654 2022-04-20
Vinorelbine Plus Apatinib Versus Vinorelbine in Advanced Triple-Negative Breast Cancer
Fudan University
Phase 2 Completed